Drugs / NBS10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01495364 | Dec 2011 → Jun 2014 | ST-elevation myocardial infarction | Lisata Therapeutics, Inc. | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NBS10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01495364 ↗ |
| Modality | Cell therapy | “cell-based therapy” PMID 27821724 ↗ Nov 2016 |
| Route | Other | “via intracoronary infusion” NCT01495364 ↗ |